Chris Calise - 11 Feb 2026 Form 4 Insider Report for Coeptis Therapeutics Holdings, Inc. (COEP)

Role: Director
Signature: /s/ Christopher Calise
Issuer symbol: COEP
Transactions as of: 11 Feb 2026
Net transactions value: +$60,192
Form type: 4
Filing time: 13 Feb 2026, 17:00:11 UTC
Previous filing: 06 Mar 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Calise Chris	Director	105 BRADFORD ROAD, SUITE 420, WEXFORD	/s/ Christopher Calise	13 Feb 2026	0001824769

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	COEP	Common stock	Options Exercise	$60,192	+5,700	+1.6%	$10.56	368,741	11 Feb 2026	Direct	F1, F3
transaction	COEP	Common stock	Award	$0	+3,250	+0.89%	$0.000000	368,741	11 Feb 2026	Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the exercise price of shares purchased upon exercise of stock options.
F2	Represents a grant of restricted stock issued in connection with an option exchange program where the Reporting Person surrendered underwater options in exchange for a grant of restricted stock.
F3	Includes (i) 49,500 shares of common stock that are owned by CJC Investment Trust (a Trust in which Mr. Calise is a control person), and (ii) 47,106 shares of common stock that are issuable under currently exercisable warrants.